Nanoform Finland Plc, a nanoparticle medicine enabling company, has been awarded a Good Manufacturing Practices (GMP) certification by the Finnish Medicines Agency, FIMEA. The GMP status allows Nanoform to manufacture an investigational drug, developed using its CESS nanoparticle engineering platform, for use in clinical trials.   The GMP certification represents an important milestone for Nanoform as it continues to increase the commercial reach of its CESS technology, which reduces the size ...